Annual EBITDA:
$17.12B+$3.70B(+27.56%)Summary
- As of today, AZN annual EBITDA is $17.12 billion, with the most recent change of +$3.70 billion (+27.56%) on December 31, 2024.
- During the last 3 years, AZN annual EBITDA has risen by +$12.01 billion (+234.85%).
- AZN annual EBITDA is now at all-time high.
Performance
AZN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$5.09B+$230.38M(+4.74%)Summary
- As of today, AZN quarterly EBITDA is $5.09 billion, with the most recent change of +$230.38 million (+4.74%) on September 30, 2025.
- Over the past year, AZN quarterly EBITDA has increased by +$488.24 million (+10.61%).
- AZN quarterly EBITDA is now at all-time high.
Performance
AZN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$19.25B+$488.24M(+2.60%)Summary
- As of today, AZN TTM EBITDA is $19.25 billion, with the most recent change of +$488.24 million (+2.60%) on September 30, 2025.
- Over the past year, AZN TTM EBITDA has increased by +$3.42 billion (+21.58%).
- AZN TTM EBITDA is now at all-time high.
Performance
AZN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AZN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +27.6% | +10.6% | +21.6% |
| 3Y3 Years | +234.8% | +93.4% | +104.6% |
| 5Y5 Years | +155.1% | +167.8% | +141.8% |
AZN EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +234.8% | at high | +94.9% | at high | +104.6% |
| 5Y | 5-Year | at high | +234.8% | at high | +179.4% | at high | +141.8% |
| All-Time | All-Time | at high | +2391.9% | at high | +205.4% | at high | +4663.8% |
AZN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $5.09B(+4.7%) | $19.25B(+2.6%) |
| Jun 2025 | - | $4.86B(-2.1%) | $18.76B(+4.1%) |
| Mar 2025 | - | $4.97B(+14.6%) | $18.02B(+2.7%) |
| Dec 2024 | $17.12B(+27.6%) | $4.33B(-5.9%) | $17.55B(+10.9%) |
| Sep 2024 | - | $4.60B(+11.8%) | $15.83B(+9.0%) |
| Jun 2024 | - | $4.12B(-8.5%) | $14.52B(+7.8%) |
| Mar 2024 | - | $4.50B(+72.3%) | $13.47B(+5.2%) |
| Dec 2023 | $13.42B(+47.7%) | $2.61B(-20.6%) | $12.81B(-0.6%) |
| Sep 2023 | - | $3.29B(+7.1%) | $12.89B(+5.4%) |
| Jun 2023 | - | $3.07B(-20.0%) | $12.23B(+9.4%) |
| Mar 2023 | - | $3.84B(+42.6%) | $11.18B(+17.6%) |
| Dec 2022 | $9.09B(+77.7%) | $2.69B(+2.2%) | $9.51B(+1.0%) |
| Sep 2022 | - | $2.63B(+30.5%) | $9.41B(-0.6%) |
| Jun 2022 | - | $2.02B(-6.7%) | $9.46B(+2.1%) |
| Mar 2022 | - | $2.16B(-16.6%) | $9.27B(-5.0%) |
| Dec 2021 | $5.11B(-36.8%) | $2.60B(-3.5%) | $9.75B(+3.5%) |
| Sep 2021 | - | $2.69B(+47.5%) | $9.42B(+9.1%) |
| Jun 2021 | - | $1.82B(-31.2%) | $8.63B(-1.6%) |
| Mar 2021 | - | $2.65B(+17.0%) | $8.78B(+8.1%) |
| Dec 2020 | $8.08B(+20.4%) | $2.26B(+19.0%) | $8.12B(+1.9%) |
| Sep 2020 | - | $1.90B(-3.3%) | $7.96B(+5.2%) |
| Jun 2020 | - | $1.97B(-1.1%) | $7.57B(+10.8%) |
| Mar 2020 | - | $1.99B(-5.9%) | $6.83B(+2.8%) |
| Dec 2019 | $6.71B(-5.6%) | $2.11B(+40.1%) | $6.64B(-11.7%) |
| Sep 2019 | - | $1.51B(+22.4%) | $7.53B(-1.0%) |
| Jun 2019 | - | $1.23B(-31.6%) | $7.60B(-2.9%) |
| Mar 2019 | - | $1.80B(-39.9%) | $7.83B(+10.8%) |
| Dec 2018 | $7.11B(+7.4%) | $2.99B(+89.6%) | $7.07B(+36.5%) |
| Sep 2018 | - | $1.58B(+8.2%) | $5.18B(-4.3%) |
| Jun 2018 | - | $1.46B(+40.6%) | $5.41B(+6.6%) |
| Mar 2018 | - | $1.04B(-6.1%) | $5.08B(-9.6%) |
| Dec 2017 | $6.62B(-9.0%) | $1.10B(-39.0%) | $5.61B(-18.7%) |
| Sep 2017 | - | $1.81B(+61.4%) | $6.91B(+0.1%) |
| Jun 2017 | - | $1.12B(-28.8%) | $6.90B(+4.6%) |
| Mar 2017 | - | $1.57B(-34.3%) | $6.59B(-1.7%) |
| Dec 2016 | $7.28B(+4.5%) | $2.40B(+33.0%) | $6.71B(+11.5%) |
| Sep 2016 | - | $1.80B(+120.0%) | $6.02B(+5.3%) |
| Jun 2016 | - | $819.24M(-51.5%) | $5.72B(-13.0%) |
| Mar 2016 | - | $1.69B(-0.9%) | $6.57B(+1.1%) |
| Dec 2015 | $6.96B(+26.8%) | $1.71B(+13.5%) | $6.50B(+16.5%) |
| Sep 2015 | - | $1.50B(-10.3%) | $5.58B(-2.7%) |
| Jun 2015 | - | $1.68B(+3.5%) | $5.74B(-5.3%) |
| Mar 2015 | - | $1.62B(+105.9%) | $6.05B(-4.7%) |
| Dec 2014 | $5.49B(-34.2%) | $786.01M(-52.6%) | $6.35B(-35.4%) |
| Sep 2014 | - | $1.66B(-16.9%) | $9.83B(-4.5%) |
| Jun 2014 | - | $1.99B(+4.0%) | $10.30B(-2.2%) |
| Mar 2014 | - | $1.92B(-55.1%) | $10.53B(-2.0%) |
| Dec 2013 | $8.34B(-21.9%) | $4.27B(+101.1%) | $10.74B(+14.2%) |
| Sep 2013 | - | $2.12B(-4.4%) | $9.40B(-6.4%) |
| Jun 2013 | - | $2.22B(+4.4%) | $10.04B(-1.7%) |
| Mar 2013 | - | $2.13B(-27.4%) | $10.21B(-4.8%) |
| Dec 2012 | $10.68B(-30.6%) | $2.93B(+6.1%) | $10.73B(+1.3%) |
| Sep 2012 | - | $2.76B(+15.3%) | $10.59B(-4.3%) |
| Jun 2012 | - | $2.40B(-9.2%) | $11.07B(-8.7%) |
| Mar 2012 | - | $2.64B(-5.5%) | $12.12B(-9.4%) |
| Dec 2011 | $15.39B(+4.4%) | $2.79B(-13.8%) | $13.38B(-12.7%) |
| Sep 2011 | - | $3.24B(-6.1%) | $15.34B(+2.9%) |
| Jun 2011 | - | $3.45B(-11.6%) | $14.91B(+0.8%) |
| Mar 2011 | - | $3.90B(-17.8%) | $14.80B(+1.2%) |
| Dec 2010 | $14.74B(+5.7%) | $4.75B(+68.9%) | $14.62B(+8.7%) |
| Sep 2010 | - | $2.81B(-15.8%) | $13.45B(-5.8%) |
| Jun 2010 | - | $3.34B(-10.4%) | $14.28B(+1.5%) |
| Mar 2010 | - | $3.72B(+3.9%) | $14.07B(+2.7%) |
| Dec 2009 | $13.95B(+10.5%) | $3.58B(-1.6%) | $13.69B(+12.0%) |
| Sep 2009 | - | $3.64B(+16.5%) | $12.23B(+6.3%) |
| Jun 2009 | - | $3.12B(-6.7%) | $11.51B(+3.3%) |
| Mar 2009 | - | $3.35B(+58.4%) | $11.14B(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | $12.62B(+26.8%) | $2.12B(-27.4%) | $10.65B(-0.9%) |
| Sep 2008 | - | $2.92B(+5.7%) | $10.75B(+4.7%) |
| Jun 2008 | - | $2.76B(-3.5%) | $10.26B(+4.9%) |
| Mar 2008 | - | $2.86B(+29.0%) | $9.79B(+4.0%) |
| Dec 2007 | $9.95B(+4.1%) | $2.22B(-8.8%) | $9.41B(-1.0%) |
| Sep 2007 | - | $2.43B(+6.4%) | $9.50B(+1.3%) |
| Jun 2007 | - | $2.28B(-8.1%) | $9.38B(+0.7%) |
| Mar 2007 | - | $2.48B(+7.6%) | $9.32B(+3.5%) |
| Dec 2006 | $9.56B(+22.1%) | $2.31B(-0.1%) | $9.01B(+4.0%) |
| Sep 2006 | - | $2.31B(+4.4%) | $8.66B(+5.1%) |
| Jun 2006 | - | $2.21B(+1.9%) | $8.24B(+2.8%) |
| Mar 2006 | - | $2.17B(+10.9%) | $8.01B(+5.5%) |
| Dec 2005 | $7.83B(+34.6%) | $1.96B(+3.7%) | $7.60B(+4.8%) |
| Sep 2005 | - | $1.89B(-5.1%) | $7.25B(+6.6%) |
| Jun 2005 | - | $1.99B(+13.5%) | $6.80B(+11.6%) |
| Mar 2005 | - | $1.76B(+8.9%) | $6.09B(+5.9%) |
| Dec 2004 | $5.82B(+9.7%) | $1.61B(+11.6%) | $5.76B(+4.4%) |
| Sep 2004 | - | $1.44B(+12.3%) | $5.52B(-1.3%) |
| Jun 2004 | - | $1.29B(-9.3%) | $5.59B(-2.4%) |
| Mar 2004 | - | $1.42B(+3.4%) | $5.73B(-2.9%) |
| Dec 2003 | $5.30B(+6.7%) | $1.37B(-9.5%) | $5.90B(+0.9%) |
| Sep 2003 | - | $1.52B(+6.5%) | $5.85B(+5.6%) |
| Jun 2003 | - | $1.42B(-10.6%) | $5.54B(+21.0%) |
| Mar 2003 | - | $1.59B(+20.9%) | $4.58B(+1.5%) |
| Dec 2002 | $4.97B(-1.0%) | $1.32B(+9.2%) | $4.51B(+1.1%) |
| Sep 2002 | - | $1.20B(+160.2%) | $4.46B(+1.9%) |
| Jun 2002 | - | $462.98M(-69.6%) | $4.38B(-13.6%) |
| Mar 2002 | - | $1.52B(+20.5%) | $5.07B(+4.6%) |
| Dec 2001 | $5.02B(+2.1%) | $1.26B(+12.6%) | $4.84B(-0.5%) |
| Sep 2001 | - | $1.12B(-2.5%) | $4.87B(-1.3%) |
| Jun 2001 | - | $1.15B(-11.5%) | $4.93B(-1.7%) |
| Mar 2001 | - | $1.30B(+0.9%) | $5.02B(+2.2%) |
| Dec 2000 | $4.91B(+9.2%) | $1.29B(+8.7%) | $4.91B(+11.3%) |
| Sep 2000 | - | $1.19B(-4.3%) | $4.41B(+0.4%) |
| Jun 2000 | - | $1.24B(+3.9%) | $4.39B(-0.7%) |
| Mar 2000 | - | $1.19B(+50.7%) | $4.42B(-42.9%) |
| Dec 1999 | $4.50B(+38.5%) | $792.00M(-32.2%) | $7.75B(+264.3%) |
| Sep 1999 | - | $1.17B(-7.9%) | $2.13B(-35.3%) |
| Jun 1999 | - | $1.27B(-71.9%) | $3.29B(+13.8%) |
| Mar 1999 | - | $4.52B(+193.6%) | $2.89B(+268.0%) |
| Dec 1998 | $3.25B(+44.7%) | -$4.83B(-307.3%) | $785.10M(-34.9%) |
| Sep 1998 | - | $2.33B(+168.1%) | $1.21B(+23.7%) |
| Jun 1998 | - | $869.00M(-64.1%) | $975.55M(-59.2%) |
| Mar 1998 | - | $2.42B(+154.8%) | $2.39B(+5.9%) |
| Dec 1997 | $2.24B(+4.4%) | -$4.41B(-310.1%) | $2.26B(-40.9%) |
| Sep 1997 | - | $2.10B(-8.1%) | $3.82B(-5.3%) |
| Jun 1997 | - | $2.28B(0.0%) | $4.03B(+0.1%) |
| Mar 1997 | - | $2.28B(+180.2%) | $4.03B(+0.1%) |
| Dec 1996 | $2.15B(+59.1%) | -$2.85B(-223.1%) | $4.02B(+89.9%) |
| Sep 1996 | - | $2.31B(+1.5%) | $2.12B(+21.8%) |
| Jun 1996 | - | $2.28B(0.0%) | $1.74B(+1184.3%) |
| Mar 1996 | - | $2.28B(+147.9%) | -$160.41M(+62.0%) |
| Dec 1995 | $1.35B(-8.5%) | -$4.75B(-345.6%) | -$421.81M(-240.2%) |
| Sep 1995 | - | $1.94B(+411.0%) | $300.94M(+153.4%) |
| Jun 1995 | - | $378.70M(-81.2%) | $118.74M(-92.5%) |
| Mar 1995 | - | $2.02B(+150.1%) | $1.58B(+12.9%) |
| Dec 1994 | $1.48B(+6.0%) | -$4.03B(-329.9%) | $1.40B(-8.8%) |
| Sep 1994 | - | $1.75B(-4.6%) | $1.53B(+16.4%) |
| Jun 1994 | - | $1.84B(0.0%) | $1.32B(+7.2%) |
| Mar 1994 | - | $1.84B(+147.2%) | $1.23B(+7.8%) |
| Dec 1993 | $1.39B(+102.8%) | -$3.90B(-353.4%) | $1.14B(-77.4%) |
| Sep 1993 | - | $1.54B(-12.1%) | $5.03B(+44.0%) |
| Jun 1993 | - | $1.75B(0.0%) | $3.50B(+100.0%) |
| Mar 1993 | - | $1.75B | $1.75B |
| Dec 1992 | $687.06M(-59.1%) | - | - |
| Dec 1991 | $1.68B(+22.2%) | - | - |
| Dec 1990 | $1.37B | - | - |
FAQ
- What is AstraZeneca PLC annual EBITDA?
- What is the all-time high annual EBITDA for AstraZeneca PLC?
- What is AstraZeneca PLC annual EBITDA year-on-year change?
- What is AstraZeneca PLC quarterly EBITDA?
- What is the all-time high quarterly EBITDA for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly EBITDA year-on-year change?
- What is AstraZeneca PLC TTM EBITDA?
- What is the all-time high TTM EBITDA for AstraZeneca PLC?
- What is AstraZeneca PLC TTM EBITDA year-on-year change?
What is AstraZeneca PLC annual EBITDA?
The current annual EBITDA of AZN is $17.12B
What is the all-time high annual EBITDA for AstraZeneca PLC?
AstraZeneca PLC all-time high annual EBITDA is $17.12B
What is AstraZeneca PLC annual EBITDA year-on-year change?
Over the past year, AZN annual EBITDA has changed by +$3.70B (+27.56%)
What is AstraZeneca PLC quarterly EBITDA?
The current quarterly EBITDA of AZN is $5.09B
What is the all-time high quarterly EBITDA for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly EBITDA is $5.09B
What is AstraZeneca PLC quarterly EBITDA year-on-year change?
Over the past year, AZN quarterly EBITDA has changed by +$488.24M (+10.61%)
What is AstraZeneca PLC TTM EBITDA?
The current TTM EBITDA of AZN is $19.25B
What is the all-time high TTM EBITDA for AstraZeneca PLC?
AstraZeneca PLC all-time high TTM EBITDA is $19.25B
What is AstraZeneca PLC TTM EBITDA year-on-year change?
Over the past year, AZN TTM EBITDA has changed by +$3.42B (+21.58%)